
Jury says Apple infringed Masimo blood oxygen patent
A federal jury handed Masimo a win in its longstanding legal battle with Apple, finding the company infringed a Masimo patent covering blood-oxygen monitoring technology visible in Apple Watch Workout and Heart Rate features. Apple disputed the verdict, saying the single patent expired in 2022 and is specific to historic...








